AstraZeneca's Imfinzi has the potential to 'redefine care for patients with gastrointestinal cancers' interim analysis shows 08-Jun-2023 By Liza Laws A new treatment approach to improve outcomes for patients with earlier stages of gastric and gastroesophageal junction cancers has had positive high-level results from a planned interim analysis of a phase 3 trial.